increased lung non-small cell carcinoma incidence_Kras<tm4Tyj>/Kras<+>,Trp53<tm1Lejo>/Trp53<tm1Lejo>

http://metadb.riken.jp/0008716I129S4SvJaeKrastm4TyjKrasTrp53tm1LejoTrp53tm1LejoKrasKrastm4TyjTrp53tm1Lejo

increased lung non-small cell carcinoma incidence_Kras<tm4Tyj>/Kras<+>,Trp53<tm1Lejo>/Trp53<tm1Lejo>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• Kirsten rat sarcoma viral oncogene homolog
  http://metadb.riken.jp/db/mgi_rdf/MGI:96680
• transformation related protein 53
  http://metadb.riken.jp/db/mgi_rdf/MGI:98834

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Kras<tm4Tyj>/Kras<+>,Trp53<tm1Lejo>/Trp53<tm1Lejo>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Kras<+>|Kras<tm4Tyj>|Trp53<tm1Lejo>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129S4/SvJae

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• increased lung non-small cell carcinoma incidence
  http://purl.obolibrary.org/obo/MP_0008716

文献

http://purl.org/net/cito/citesAsAuthority

• Mallika. Singh, et.al., Anti-VEGF antibody therapy does not promote metastasis in genetically engineered mouse tumour models., The Journal of pathology, 2012, 227
  http://rdf.ncbi.nlm.nih.gov/pubmed/22611036